G. Le Guenno

Inserm — France

Medicine · Health Sciences

33h-index4.7kcitations164works10.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Vasculitis and related conditions(26), Otitis Media and Relapsing Polychondritis(24), Platelet Disorders and Treatments(23), Sarcoidosis and Beryllium Toxicity Research(14), Blood groups and transfusion(13)

Publications162 total

Atteintes articulaires chez les patients atteints de VEXAS syndrome : étude rétrospective multicentrique française du groupe FREVEX
Revue du Rhumatisme·2025Open Access
Suivi à long terme des vascularites cryoglobulinémiques mixtes non infectieuses
La Revue de Médecine Interne·2025
IRF4 haploinsufficiency in a multiplex family with Whipple’s disease
Journal of Human Immunity·2025Open Access
Characteristics and prognostic significance of myelodysplastic syndrome (MDS)-related features in vexas syndrome
Blood·2025Open Access
Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study
American Journal of Hematology·2025· 1 citedOpen Access
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome
Blood·2025· 6 cited
Entéropathies inflammatoires associées aux déficits immunitaires humoraux primitifs
La Revue de Médecine Interne·2025
Dermatoses neutrophiliques associées aux syndromes myélodysplasiques : une étude cas-témoins
La Revue de Médecine Interne·2025
Cytopénies auto immunes sous double immunothérapie : « Et une, et deux, et trois… » !
La Revue de Médecine Interne·2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX
Blood·2025· 17 citedOpen Access
Neurological manifestations in patients with VEXAS syndrome
Journal of Neurology·2025· 8 cited
Nonischemic Cardiac Manifestations in VEXAS Syndrome
JAMA Network Open·2024· 8 citedOpen Access
A Clinicopathological Description of Kidney Features in VEXAS Syndrome
Kidney International Reports·2024· 5 citedOpen Access
Pneumocystis jirovecii pneumonia in non-HIV patients: need for a more extended prophylaxis
Frontiers in Medicine·2024· 1 citedOpen Access
OP0243 EFFICACY AND SAFETY OF TARGETED THERAPIES IN VEXAS SYNDROME: RETROSPECTIVE STUDY FROM THE FRENVEX
Annals of the Rheumatic Diseases·2024· 5 cited
OP0231 EFFICACY AND SAFETY OF AZACITIDINE FOR PATIENTS WITH VEXAS SYNDROME: RETROSPECTIVE STUDY FROM THE FRENVEX
Annals of the Rheumatic Diseases·2024· 3 cited
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Annals of the Rheumatic Diseases·2024· 54 cited
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
Frontiers in Immunology·2024· 14 citedOpen Access
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Nature Communications·2024· 78 citedOpen Access
Syndrome des antiphospholipides et hémorragie intra-alvéolaire : une étude française multicentrique et rétrospective
Revue des Maladies Respiratoires Actualités·2024
page 1 of 9Next →

Frequent Co-authors

Benjamin Terrier(18), Estibaliz Lazaro(11), M. Ruivard(11), Loı̈c Guillevin(10), Louis Terriou(10), Mikaël Ebbo(10), A. Mékinian(10), Maxime Samson(9), Sylvain Audia(9), Sophie Georgin‐Lavialle(8), Maël Heiblig(8), Pierre Fenaux(8), Olivier Kosmider(8), Lionel Galicier(8), Boris Bienvenu(7), Hervé Lobbes(7), Jean‐Emmanuel Kahn(7), Marc Michel(7), Bertrand Godeau(7), V. Rieu(7)